Lv3
330 积分 2025-06-21 加入
FDA approved fluorine-containing drugs in 2023
2天前
已完结
AT1, a small molecular degrader of BRD4 based on proteolysis targeting chimera technology alleviates renal fibrosis and inflammation in diabetic nephropathy
2个月前
已完结
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines
2个月前
已完结
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines
2个月前
已关闭
BRD4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastoma
2个月前
已完结
BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation
2个月前
已完结
Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia
2个月前
已完结
Brd4 proteolysis-targeting chimera nanoparticles sensitized colorectal cancer chemotherapy
2个月前
已完结
Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell lines
2个月前
已完结
BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3
2个月前
已完结
皖公网安备34019202002308
